Clinical Trial

Efficacy and Safety of Photodynamic Therapy for CIN3

Recruiting
View on ClinicalTrials.gov →
Summary
To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical intraepithelial neoplasia 3(CIN 3)in women in the real world
Trial Details
NCT Number NCT07009327
Lead Sponsor Peking University Third Hospital
Conditions Precancerous Cervical Lesion
Enrollment 100 participants
Start Date 2024-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-06